• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

AGA MEDICAL CORPORATION AMPLATZER SEPTAL OCCLUDER; TRANSCATHETER SEPTAL OCCLUDER Back to Search Results
Model Number 9-ASD-040
Device Problem Biocompatibility (2886)
Patient Problems Pleural Effusion (2010); Cardiac Tamponade (2226); Pericardial Effusion (3271)
Event Type  Injury  
Manufacturer Narrative
The results/method and conclusion codes along with investigation results will be provided in a subsequent submission.
 
Event Description
The article "not just another large atrial septal defect: complex anatomy, challenging procedure, and an unusual complication" was reviewed.This article is a case report of a patient with a complex atrial septal defect in whom a 40-mm amplatzer septal occluder was implanted.During deployment of the device, deployment maneuvers led to an immediate pericardial effusion that was closely monitored and uneventfully drained 11 days later after imaging showed signs of tamponade.The occluder was surgically extracted 50 days following implantation due to recurrence of pericardial effusion, chest pain and dyspnea.The defect was surgically repaired, and the patient was reported to be discharged.The primary author is raymond n.Haddad, md, of department of pediatrics, hotel dieu de france university medical center, saint joseph university, beirut, lebanon.The corresponding email is: raymondhaddad@live.Com.
 
Manufacturer Narrative
As reported in a research article, a patient had a pericardial effusion during the deployment of the device, which reoccurred 50 days after the implant resulting in the device being explanted.The patient also experienced chest pain and dyspnea.A more comprehensive assessment could not be performed as the event was non-contemporaneously reported through a literature review and no device was received for analysis.Based on the information received, the cause of the reported incident could not be conclusively determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMPLATZER SEPTAL OCCLUDER
Type of Device
TRANSCATHETER SEPTAL OCCLUDER
Manufacturer (Section D)
AGA MEDICAL CORPORATION
5050 nathan lane north
plymouth MN 55442
MDR Report Key10299861
MDR Text Key200814910
Report Number2135147-2020-00322
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Type of Report Initial,Followup
Report Date 08/17/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/20/2020
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number9-ASD-040
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received08/14/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age59 YR
-
-